Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCOA1 | Q15788 | 1/20 | 0.54 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 8/20 | 0.52 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 9/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | CCR6 | P51684 | 2/20 | 0.45 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12570766 | 1.00 | NCOA1 (0.54) | NCOA1NCOA3GAARAB9ASMN1; SMN2 | |
| SCHEMBL180203 | 0.78 | MAPT (0.61) | GAARAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL180204 | 0.78 | MAPT (0.61) | GAARAB9ASMN1; SMN2MAPTMEN1 | |
| SCHEMBL12720808 | 0.76 | NPC1 (0.69) | GAARAB9ASMN1; SMN2NPC1MAPT | |
| SCHEMBL20101098 | 0.74 | MAPT (0.73) | GAARAB9ASMN1; SMN2NPC1MAPT | |
| SCHEMBL6715793 | 0.74 | PAX8 (0.67) | GAARAB9ASMN1; SMN2NPC1MAPT | |
| SCHEMBL20101085 | 0.74 | PAX8 (0.67) | GAARAB9ASMN1; SMN2NPC1MAPT | |
| SCHEMBL6715790 | 0.74 | PAX8 (0.67) | GAARAB9ASMN1; SMN2NPC1MAPT | |
| SCHEMBL1973299 | 0.73 | RAB9A (0.59) | GAARAB9ASMN1; SMN2NPC1MAPT | |
| SCHEMBL2269809 | 0.72 | NPC1 (0.69) | GAARAB9ASMN1; SMN2NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2402081-A1 | AMMONIA DECOMPOSITION CATALYST | Hitachi Zosen Corporation (JP) | 2012-01-04 | — | — | EP | disclosed |
| US-7960501-B2 | Catalyst using hydrazone compound, hydrazone polymer compound, and catalyst using hydrazone polymer compound | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2011-06-14 | — | — | US | disclosed |
| US-7951903-B2 | Hydrazone compound, hydrazone compound for forming complex, ligand for forming metal complex, and monomer for manufacturing polymer compound | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20090062506-A1 | CATALYST USING HYDRAZONE COMPOUND, HYDRAZONE POLYMER COMPOUND, AND CATALYST USING HYDRAZONE POLYMER COMPOUND | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090062507-A1 | HYDRAZONE COMPOUND, HYDRAZONE COMPOUND FOR FORMING COMPLEX, LIGAND FOR FORMING METAL COMPLEX, AND MONOMER FOR MANUFACTURING POLYMER COMPOUND | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062507-A1 | HYDRAZONE COMPOUND, HYDRAZONE COMPOUND FOR FORMING COMPLEX, LIGAND FOR FORMING METAL COMPLEX, AND MONOMER FOR MANUFACTURING POLYMER COMPOUND | PBRM1, AP1M1, PUM1 | NCOA1 1442/4885NCOA3 3440/4885GAA 3543/4885 |
| US-20090062506-A1 | CATALYST USING HYDRAZONE COMPOUND, HYDRAZONE POLYMER COMPOUND, AND CATALYST USING HYDRAZONE POLYMER COMPOUND | PKD1, HDAC1, HDAC11 | NCOA1 2006/4885NCOA3 4258/4885GAA 1154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.